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Directed cell migration is mediated by cycles of protrusion, adhesion, traction generation on the extracellular matrix and
retraction. However, how the events after protrusion are timed, and what dictates their temporal order is completely
unknown. We used acute epidermal growth factor (EGF) stimulation of epidermal keratinocytes to initiate the cell
migration cycle to study the mechanism of the timing of adhesion, traction generation, and de-adhesion. Using micro-
scopic and biochemical assays, we surprisingly found that at 2 min after EGF stimulation protrusion, activation of
myosin-II, traction generation, adhesion assembly, and paxillin phosphorylation occurred nearly simultaneously, fol-
lowed by a 10-min delay during which paxillin became dephosphorylated before cell retraction. Inhibition of myosin-II
blocked both the EGF-stimulated paxillin phosphorylation and cell retraction, and a paxillin phosphomimic blocked
retraction. These results suggest that EGF-mediated activation of myosin-II acts as a mechanical signal to promote a cycle
of paxillin phosphorylation/dephosphorylation that mediates a cycle of adhesion strengthening and weakening that
delays cell retraction. Thus, we reveal for the first time a mechanism by which cells may temporally segregate protrusion,
adhesion, and traction generation from retraction during EGF-stimulated cell migration.
INTRODUCTION
Directed cell migration is mediated by integration of the
biophysical processes of protrusion, adhesion, traction gen-
eration on the extracellular matrix (ECM), and retraction
(Lauffenburger and Horwitz, 1996). Much emphasis has
been placed on delineating the spatial control of these pro-
cesses. However, equally important is their temporal control
(Giannone et al., 2004; Ji et al., 2008). The timing of protru-
sion, adhesion, traction generation, and retraction with re-
spect to each other is critical, because they must occur cy-
clically in order to drive cell migration (Lauffenburger and
Horwitz, 1996). How does the cell control such timing? One
possibility is that there may be overlying regulatory mech-
anisms not involved in the processes themselves, like check-
points in the cell division cycle. However, processes of the
cell migration cycle, particularly adhesion, traction genera-
tion, and retraction are intimately coupled by feedback loops
between one another (Burridge and ChrzanowskaWodnicka,
1996). Their interconnected regulation kinetically couples
these processes, suggesting different principles than check-
points are controlling their temporal ordering. Here, we
focus on identifying the mechanism of temporal regulation
of adhesion, traction generation and retraction.
Traction generation and retraction are intrinsically inter-
dependent because they both involve regulating the strength
of two components: contraction and adhesion. Traction for
pulling the cell body forward requires coupling contraction
force generated by myosin motors in the cytoskeleton to
adhesion to the ECM via integrin-mediated focal adhesions
(FAs). Retraction requires release of FAs and transmission of
contractile forces through the cytoskeleton to mechanically
pull protrusions in toward the cell body. Thus, in order to
mediate traction, adhesion must be stronger than contrac-
tion, whereas in order to mediate retraction, adhesion must
be weaker than contraction. Contraction during cell migra-
tion is thought to be primarily mediated by myosin-II mo-
tors, which are activated by phosphorylation of their myo-
sin-II regulatory light chains (MRLC; Adelstein and Conti,
1975) by kinases such as rho-kinase (ROCK; Amano et al.,
1996) and myosin light chain kinase (MLCK; Pires et al.,
1974). Adhesion can be regulated by signaling networks that
change FA protein composition and phosphorylation state,
strengthening or weakening FAs (Shi and Boettiger, 2003;
Zaidel-Bar et al., 2007b). These same signaling networks can
also modulate myosin-II contractile activity (Burridge and
ChrzanowskaWodnicka, 1996). Because FAs are mechano-
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sensitive (Bershadsky et al., 2003), their biochemical status is
dependent on the level of force impinged on them (Gian-
none and Sheetz, 2006). Below some threshold of adhesion
strength, both externally applied or myosin-II–mediated in-
ternally applied contractile forces on FAs promotes their
growth (Rottner et al., 1999; Riveline et al., 2001; Galbraith et
al., 2002). However, above that threshold, force detaches FAs
by breaking either the actin–adhesion or adhesion–ECM
linkages (Palecek et al., 1996; Hu et al., 2007). Consequently,
the proper timing of traction generation and retraction with
respect to each other during cell migration must involve a
complex interplay between mechanical and biochemical sig-
nals that regulate the relative strengths of contraction and
adhesion.
During cell migration, integrin-based FAs go through an
assembly-maturation-disassembly cycle (Zamir and Geiger,
2001). FA maturation has been implicated in such diverse
cellular responses as migration (Beningo et al., 2001), epithe-
lial morphogenesis (Paszek et al., 2005) and stem cell differ-
entiation (Engler et al., 2006). During migration, FAs are
initiated as tiny focal complexes that assemble underneath
the lamellipodium. A subpopulation of focal complexes dis-
assembles within minutes, and the remainder grow into
mature FAs (Choi et al., 2008). These mature FAs then either
disassemble within 10–20 min or mature further into stable
fibrillar adhesions that do not promote migration, but me-
diate ECM remodeling (Laukaitis et al., 2001; Zaidel-Bar et
al., 2003). FA maturation is thought to inhibit cell migration
and has been loosely defined as a morphological change in
which FAs elongate and recruit more protein. Along with
this morphological change is a less well-defined process of
compositional change (Zamir and Geiger, 2001; Zamir et al.,
2008). Of the 156 known FA components (Zaidel-Bar et al.,
2007a), only a handful are known to be specific for a FA
maturation state. For example, focal complexes contain v3
integrin, paxillin, focal adhesion kinase (Fak), and talin,
whereas mature FAs additionally contain vinculin, vasp,
and 5 integrin, and fibrillar adhesions additionally contain
tensin (Laukaitis et al., 2001; von Wichert et al., 2003; Zaidel-
Bar et al., 2003). Driving this maturation is FAK down-
regulation leading to the dephosphorylation of paxillin on
tyrosines 31 and 118, which in turn promotes FA stability
and recruitment of tensin (Zaidel-Bar et al., 2007b). FA mat-
uration may also regulate biophysical properties. Small, im-
mature FAs transmit more traction force per unit area to the
ECM, and thus may adhere more tightly, than do larger,
mature FAs, allowing them to resist protrusive forces
(Beningo et al., 2001; Ji et al., 2008). The time required for FA
maturation, as well as the changes it induces in adhesion
strength suggest that maturation may not only slow migra-
tion, but also could set the timing of when contraction
promotes traction generation versus retraction.
Because promigratory growth factors activate signaling
pathways involved in contraction and FA protein phosphor-
ylation and dephosphorylation, it is possible that growth
factors could control FA maturation as a means of modulat-
ing cell migration. Epidermal growth factor (EGF) is a well-
characterized growth factor that stimulates epidermal kera-
tinocyte migration during wound healing (Li et al., 2004).
Acute EGF stimulation is a widely used model to induce cell
migration in culture (Segall et al., 1996; Wells et al., 1998).
Indeed, much is known about how EGF promotes kinet-
ically defined phases of actin polymerization to drive
lamellipodial protrusion in the first step of the migration
cycle (Mouneimne et al., 2004). However, less is known
about how EGF regulates the timing of adhesion, traction
generation, and de-adhesion. It is known that EGF induces
phosphorylation of MRLC through MLCK to promote my-
osin-II contraction in fibroblasts (Iwabu et al., 2004). How-
ever, in epithelial cells, EGF stimulation also activates Rho
GTPase (Russell et al., 2003), which promotes ROCK to ac-
tivate myosin-II by phosphorylating MRLC (Amano et al.,
1996) and phosphorylating and inactivating myosin-II phos-
phatase (Kimura et al., 1996). EGF also increases the amount
of morphologically immature focal complexes and decreases
the amount of morphologically mature FAs (Bailly et al.,
1998; Xie et al., 1998). This is thought to be mediated by Erk
through calpain to promote proteolysis of FA proteins and
thus drive adhesion disassembly (Xie et al., 1998). EGF also
alters phosphorylation of Fak and paxillin; however, the
context or timing of this regulation may be important be-
cause reports differ as to whether EGF promotes phosphor-
ylation or dephosphorylation of these proteins (Tapia et al.,
1999; Sieg et al., 2000; Lu et al., 2001). In spite of this knowl-
edge, the kinetics of EGF-stimulated contractile and adhe-
sive functions that promote cell migration are not well un-
derstood, and it is unknown whether effects of EGF on
adhesion are mediated biochemically or mechanically.
Here, we use acute EGF stimulation of epidermal keratin-
ocytes to study the timing of events in the cell migration
cycle. We characterize a myosin-II–dependent cell retraction
response to EGF stimulation that is temporally delayed rel-
ative to protrusion. Using microscopic and biochemical as-
says, we surprisingly find that EGF stimulates several events
of the cell migration cycle near simultaneously, including
protrusion, myosin-II activation, increases in traction force
generation and the formation of immature FAs, rich in ty-
rosine-phosphorylated paxillin. We find that inhibition of
myosin-II blocks the EGF-stimulated increase in paxillin
phosphorylation and instead causes an immediate paxillin
dephosphorylation. Inhibition of paxillin dephosphorylation
by introduction of Y31E/Y118E-paxillin in a paxillin-de-
pleted background inhibits retraction. This suggests that
EGF-mediated activation of myosin-II acts as a mechanical
signal to promote paxillin phosphorylation that is required
for a period of FA maturation that delays adhesion weak-
ening relative to increases in traction generation. This may
serve as a mechanism by which the cell temporally segre-
gates adhesion and traction generation from retraction dur-
ing EGF-stimulated cell migration.
MATERIALS AND METHODS
Cell Culture and Reagents
HaCat cells, a human epidermal keratinocyte line, were grown at 37°C in 5.0%
CO2 and 95% air in growth media (DMEM, Invitrogen, Carlsbad, CA) with
penicillin and streptomycin (Invitrogen) and 10% fetal bovine serum (FBS;
Invitrogen). In all experiments, cells were serum-starved in growth medium
lacking FBS but containing 1 mg/ml fatty-acid–free bovine serum albumin
(BSA; Sigma, St. Louis, MO). Imaging experiments were conducted using
imaging medium composed of starvation medium without phenol red and
with 50 mM HEPES. An aqueous stock of human recombinant EGF (Pepro-
tech, Rocky Hill, NJ) in 1 mg/ml BSA was diluted into medium before
stimulation. Pharmacological inhibitors and antibodies used were as follows:
blebbistatin (30 M, Toronto Research Chemicals, Toronto, ON, Canada),
Y-27632 (10 M, Calbiochem, Gibbstown, NJ), ML-7 (20 M, Calbiochem),
mouse-anti pS19-MRLC (Cell Signaling Technology, Beverly, MA), mouse-
anti MRLC (MY-21, Sigma), rabbit-anti pY118-paxillin (Biosource, Camarillo,
CA), mouse-anti paxillin (349, BD Biosciences, San Jose, CA), rabbit-anti
myosin-IIA heavy chain (Biomedical Technologies, Stoughton, MA), mouse-
anti actin (C4, J. Lessard, University of Cincinnati), mouse-anti GFP (7.1 and
13.1, Roche, Indianapolis, IN), PP2 (10 M, Calbiochem), TS2/16 (1–2 mg/ml,
Pierce, Rockford, IL), P5D2 (ascites, from Mark Ginsberg, University of Cal-
ifornia, San Diego), calpeptin (10 M, Calbiochem), calpain inhibitor I (10 M,
Calbiochem), TAC554PS (1 M, from David Schlaepfer, University of Cali-
fornia, San Diego), PD-098059 (10 M, Calbiochem), cell permeable C3 trans-
ferase (0.2 g/ml, Cytoskeleton, Denver, CO). Paxillin was knocked down
using siRNA oligos for human paxillin (ON-TARGETplus SMARTpool, Dhar-
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macon, Boulder, CO) transfected into cells using electroporation (Amaxa,
Gaithersburg, MD). The paxillin constructs: paxillin-enhanced green fluores-
cent protein (EGFP), Y31/118E-paxillin-EGFP, and Y31/118F-paxillin-EGFP
were based on the original sequence for avian paxillin-EGFP (Laukaitis et al.,
2001), but were generated by synthesis (Blue Heron Biotechnology, Bothell, WA)
and included mutations rendering an internal translation site of avian paxillin
dead, as documented elsewhere (Tumbarello et al., 2005).
Western Blotting
Cells in 60-mm dishes, plated for 2 d, were serum-starved 4–6 h before EGF
stimulation and pretreated with inhibitors, where indicated. After EGF stim-
ulation, cells were washed in cold PBS (Invitrogen) with 1 mM Na3VO4 and
5 mM NaF, lysed in sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10%
glycerol, 705 mM -mercaptoethanol, and 0.05% bromophenol blue), boiled,
and frozen. Western blots were blocked with TBS-Tween (15.4 mM Tris-HCl,
pH 7.5, 137 mM NaCl, and 0.1% Tween-20) containing 5% lowfat milk or 3%
BSA, probed with antibodies and developed using chemiluminescence (ECL,
Amersham, Piscataway, NJ; or Immobilon chemiluminescent substrate, Mil-
lipore, Bedford, MA). Digital images of Western blot bands were quantified
with Metamorph software (Molecular Devices, Sunnyvale, CA) after perform-
ing local background subtraction around bands of interest.
Immunofluorescence
Cells were plated on untreated no. 1.5 coverslips in the presence of serum and
2 d later were serum-starved 4–6 h before EGF stimulation, pretreated with
inhibitors where indicated, and fixed at given time points after EGF addition.
Cells were washed in warm cytoskeleton buffer (10 mM MES, 3 mM MgCl2,
138 mM KCl, and 2 mM EGTA), fixed with 4% PFA (Electron Microscopy
Sciences, Fort Washington, PA), followed by permeabilization with 0.5%
Triton-X. Free aldehydes were reacted with 0.1 M glycine, and cells were
washed, blocked in 2% BSA TBS-Tween containing Alexa-488 phalloidin
(Invitrogen, Carlsbad, CA) and incubated with primary antibodies. Cells were
washed, incubated with fluorophore-conjugated secondary antibodies (Jack-
son ImmunoResearch Laboratories, West Grove, PA), washed again, mounted
on a slide in Dako mounting media (Molecular Probes), and sealed with nail
polish. Fixed cells were imaged on an inverted microscope (60, 1.4 NA
objective, TE-300, Nikon, Melville, NY; or 100, 1.45 NA, Axiovert 200M,
Zeiss, Thornwood, NY) using an Orca II cooled CCD (Hamamatsu, Bridge-
water, NJ). FAs were quantified by thresholding the cell by eye and drawing
regions around each FA in Metamorph. The normalized fluorescence in FAs
was calculated by dividing the background-subtracted average fluorescence
in the FA by the background-subtracted average cytosolic fluorescence.
Transmitted Light Microscopy
Coverslips of serum-starved cells prepared as above were mounted in imag-
ing media in a perfusion chamber (Warner Instruments, Hamden, CT) on an
inverted microscope with either low-resolution phase-contrast (20, 0.5NA,
TE-200, Nikon) or high-resolution differential interference contrast (DIC;
100, 1.45 NA, TE-2000-U, Nikon) optics. Images were taken with an Orca
285 (Hamamatsu) or Orca II-ERG (Hamamatsu) cooled CCD. The stage was
heated to 37°C with an airstream incubator (Nevtek, Burnsville, VA) or the
perfusion chamber heater. EGF, 5 nM, in culture media was then perfused over
the cells while imaging. Cell area was determined by drawing regions around the
cell at different time points in Metamorph. The fraction of cells that retracted was
calculated by examining four kymographs (5-pixel width) produced from four
different cell edge locations in each cell. If the cell edge did not retract in three or
four of these kymographs, cell retraction was scored as negative.
Total Internal Reflection Fluorescence Microscopy
Cells were transfected with either paxillin-mCherry or paxillin-EGFP (from A. R.
Horwitz, University of Virginia) using Fugene6 (Roche) or Lipofectamine (In-
vitrogen) and prepared for imaging as above. Cells were imaged using through-
the-objective total internal reflection fluorescence (TIRF) microscopy (100, 1.45
NA, TE-2000-U, Nikon) with an evanescent field depth of 150 nm using the
microscope described in detail elsewhere (Adams et al., 2004).
To determine the normalized level of fluorescent paxillin in FAs, raw images
were aligned using a correlation-based alignment tool (Lin Ji and Gaudenz
Danuser, Scripps, unpublished results), median filtered and background flat-
tened with kernels of 5  5 using Metamorph software. A threshold-based
segmentation was used to create a FA mask. The average fluorescence (FFA) and
area (AFA) of masked FAs, as well as cytosolic fluorescence (Fcyt) of the area
within the cell but outside of masked FAs were all measured over time. The
normalized fraction of paxillin in FAs is given by the following equation:
fpax,FA   FFA/Fcyt  eFFA0/Fcyt0  eAFAAFA0
where  is the ratio of the thickness of the FA to the thickness of the
evanescent wave field (e was chosen to be 0.75). The derivation and
estimation of parameters are shown in the Appendix in Supplemental
Materials.
Traction Microscopy
Flexible polyacrylamide substrates were generated as described previously
(Pelham and Wang, 1997). Briefly, 22-mm  30-mm no. 1.5 coverslips were
activated by serial treatments of 0.1 M NaOH, 5% 3-aminopropyltrimethyl-
oxysilane, and 0.5% glutaraldehyde, and each treatment was followed by
extensive ddH2O washing. Activated coverslips were inverted onto a 10–
15-l drop of 0.11% bis and 7.5% acrylamide, TEMED, and ammonium
persulfate containing 0.2 m far-red beads (Molecular Probes), producing an
8–20-m thick, 3-kPa gel (Yeung et al., 2005). Coverslips with attached gels
were washed in ddH2O and spun dry using a custom-made coverslip spinner.
Gels were activated for fibronectin coupling with 2 mg/ml Sulfo-SANPAH
with two 8-min UV exposures 1 inch from two 10 W 254-nm UV bulbs (UVP,
San Gabriel, CA). The coverslip with a bound, activated gel was inverted on
1 mg/ml fibronectin (FN, Calbiochem), incubated 3 h at 37°C, washed three
times with PBS, and seeded with cells. Cells were imaged on a spinning disk
confocal microscope (60, 1.4 NA, 1.5 optovar, TE-2000-E, Nikon) with the
appropriate filters as described elsewhere (Adams et al., 2003). Sequential
images of the cells (phase contrast) and the beads (fluorescence) were cap-
tured using a CoolSnap HQ2 cooled CCD (Roper Scientific, Tucson, AZ).
Images of beads were flattened using the flatten background function in
Metamorph. Images in bead movies were aligned to correct for stage drift
using a correlation tracker for beads far away from the cell boundary. Beads
were identified with subpixel accuracy by fitting a Gaussian around thresh-
olded maxima. The positions of identified beads were tracked using a corre-
lation tracker (Ji and Danuser, 2005) and were mapped onto an evenly spaced
2  2-m grid using a Gaussian interpolation algorithm (Ponti et al., 2003).
Cells were segmented by applying several filters found in Metamorph to the
phase-contrast images in the following order: erosion, dilation, gradient,
detect dark holes, and close-open. This protocol of filters gave rise to an image
that could be thresholded by intensity to form a mask of the cell. Only
displacements contained in this mask were summed and normalized to the
summed value before EGF stimulation.
RESULTS
EGF Elicits Temporally Distinct Phases of Protrusion and
Retraction
To understand how EGF stimulates cycles of protrusion,
traction force generation, and retraction to drive cell migra-
tion, we examined the sequence and timing of these events
from the initiation of a cell migration cycle. We acutely
stimulated epidermal keratinocytes (HaCats) with 5 nM EGF
(Segall et al., 1996) and imaged cells using time-lapse differ-
ential interference contrast (DIC) microscopy (Figure 1A,
Supplemental Video 1) or fixed and processed cells for lo-
calization of F-actin (Figure 1B). After stimulation, we ob-
served an F-actin-rich lamellipodium, devoid of myosin-II
(Figures 1B and 3A) that extended from the cell edge at 2–5
min after stimulation (PS). Between 5–10 min PS, the lamel-
lipodium often lifted off the substrate and ruffled (Figure 1A,
Supplemental Video 1). This was followed at 10–20 min PS
by a complete collapse of the lamellipodium and lamella in
90% of the cells, resulting in retraction that produced
retraction fibers containing bundles of F-actin (Figure 1B). At
40–60 min after EGF stimulation, the cells respread and
began to migrate faster than before EGF stimulation (not
shown). Thus, acute EGF stimulation simulates a response
that mimics the initiation of a cell motility cycle with pro-
trusion temporally segregated from retraction.
EGF Promotes Traction Force Generation before
Protrusion
During migration, traction force development between the
cell and the ECM is thought to follow protrusion and pre-
cede retraction. We wanted to identify when EGF stimula-
tion increases in traction force relative to the protrusion and
retraction phases. To achieve this, we imaged cells plated on
fibronectin-coated 3-kPa polyacrylamide substrates embed-
ded with 0.2-m fluorescent beads and determined the bead
displacements impinged by the cells during EGF stimula-
tion. EGF stimulation of cells plated on these substrates
showed the same characteristic protrusion and retraction
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responses seen in cells plated on glass (Figure 2A). Bead
positions were tracked, and displacements relative to their
positions after trypsinization were calculated and interpo-
lated on a 2  2-m grid, and their magnitudes within the
boundary of the cell were summed, resulting in a displace-
ment metric that roughly scales with total traction force
(Figure 2B, Supplemental Video 2). Before EGF stimulation,
there was a baseline level of bead displacement, indicating a
basal level of traction force exerted by the cell on the sub-
strate (Figures 2, A–C). After EGF stimulation, traction force
increase was initiated before the onset of protrusion (as
indicated by an increase in cell area, Figure 2B). Traction
force plateaued at 2–3 min PS, whereas the cell area reached
a maximum at about 5 min PS. Subsequently, the traction
force decreased when the cell began to retract at 10 min PS.
When averaged over 11 cells, the traction-mediated dis-
placement increased rapidly after EGF stimulation (tlag 
0.34 min, Supplemental Table S1), whereas the protrusion
lagged slightly behind (tlag  1.9 min, Supplemental Table
S1; Figure 2C). Both of these metrics reached their maxi-
mal levels at about 7.5 min PS (Supplemental Table S1)
and decreased through 20 min PS (Figure 2C). These
results show that EGF stimulates traction force generation
slightly before protrusion, with a subsequent lag before
cell retraction.
Retraction Is Dependent on ROCK-mediated MRLC
Phosphorylation
Increases in traction force generation after EGF stimulation
suggests that myosin-II activity may be up-regulated (Cai et
al., 2006). To determine if myosin-II contributes to increases
in traction force generation and retraction, we analyzed the
location and level of myosin-II regulatory light-chain phos-
phorylation on serine 19 (pS19-MRLC) as a readout of
myosin-II contractile activity after stimulation with EGF.
Immunolocalization showed about a twofold increase in
pS19-MRLC level after EGF stimulation on a global level
(not shown) and that pS19-MRLC and myosin-IIA heavy
chain (MHC) were both absent from lamellipodia, but dec-
orated actin bundles in the lamella during the protrusion
phase at 5 min PS (Figure 3A). Regions of actin bundles
close to FAs were not labeled with either MHC or pS19-
MRLC, suggesting that myosin-II transmits force from a
distance through the actin cytoskeleton to a subset of FAs.
At 20 min PS, both MHC and pS19-MRLC concentrated in
the retracted lamella. Immunoblotting cell lysates col-
lected after EGF stimulation revealed a very rapid in-
crease in pS19-MRLC level by 15 s PS, followed by a rapid
decay to a pseudo steady state that remained above the basal
level through 20 min PS (Figure 3B). Thus, EGF rapidly stim-
ulates activation of myosin-II first, followed closely by in-
Figure 1. EGF stimulates protrusion of an actin-rich
lamellipodium followed by cell retraction. (A) Left, time
course of DIC images of a HaCat cell stimulated with 5
nM EGF. Right, kymograph taken along the line high-
lighted in the 0-min image with the protrusion (P) and
retraction (R) phases marked with white arrows and
time after stimulation (min) below. Bottom row, a
higher magnification view of the region highlighted
with a white box. (B) Left, epifluorescence images of
cells fixed after 0, 5, and 20 min of 5 nM EGF stimulation
and stained with fluorescent phalloidin to visualize F-
actin. Right, enlarged views of the F-actin network de-
noted by the white squares. Bars, 10 m.
Figure 2. EGF stimulates an increase in trac-
tion force generation during protrusion. HaCat
cells imaged on fibronectin-coated 3-kPa poly-
acrylamide substrates containing embedded
fluorescent beads. (A) Top row, phase-contrast
micrographs (time after 5 nM EGF stimulation
in min). Middle row, raw bead displacements
(relative to their positions after trypsinization)
with the cell outline overlaid. Bottom row, in-
terpolated bead displacements, as described in
Materials and Methods, with the cell outline over-
laid. Bars, 10 m. (B) Left, the cell area (gray
line, right axis) and sum of the interpolated
displacements within the cell area (black line,
left axis) as a function of time for the cell in A.
Right, a kymograph taken along the line high-
lighted in the 0-min image in A with time after
EGF stimulation (min) below. (C) Average cell
area (gray line, right axis) and average summed
displacements (black line, left axis) for 11 cells,
each normalized to the prestimulus values be-
fore averaging. Error bars, SEM; n  11.
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creases in traction force generation and then protrusion. Re-
traction then ensues 10–20 min PS.
We next examined the requirement for myosin-II activity
in EGF-stimulated cell retraction using pharmacological per-
turbation. We pretreated HaCats for 1–2 h with ML-7 to
inhibit MLCK (20 M, Ki  0.3 M), blebbistatin to inhibit
myosin-II ATPase (30 M, Ki  2 M), or Y-27632 to inhibit
ROCK (10 M, Ki  0.14 M) and imaged them using
time-lapse microscopy (Figure 4A, Supplemental Video 3)
during stimulation with EGF. MLCK inhibition did not af-
fect EGF-induced retraction (Figure 4A); however, the cells
were less well spread (Figure 4B) and exhibited protrusion
and ruffling similar to control cells. In contrast, inhibition of
myosin-II ATPase or ROCK activity both blocked EGF-in-
duced retraction. Both of these treatments also slightly tem-
pered the extent (but not the timing) of protrusion compared
with controls, likely because they both caused increased
spreading before EGF treatment (Figure 4, A and B).
Consistent with these data were the affect of pretreatment
with the kinase inhibitors on the pS19-MRLC level measured
by immunoblotting (Figure 4C). This analysis showed that
ML-7 did not affect the EGF-induced pS19-MRLC increase in
HaCat cells, even at 15 s of EGF simulation (not shown),
contrary to reports in other cell types (Iwabu et al., 2004).
However, Y-27632 eliminated most of the EGF-induced in-
crease in pS19-MRLC (Figure 4C). Immunostaining showed
that ROCK inhibition blocked the EGF-stimulated increase in
pS19-MRLC level in the lamella (compare Figure 3A with
Figure 5). Interestingly, EGF still stimulated marginal S19-
MRLC phosphorylation behind the lamellipodia (Figure 5),
similar to the localization of pS19-MRLC in unstimulated cells
(Totsukawa et al., 2004), even though global pS19-MRLC levels
were reduced (Figure 4C). Together, these data support the
notion that EGF stimulates rapid ROCK-dependent activation
of myosin-II and that contraction is required for EGF-induced
cell retraction.
EGF Stimulates Acute FA Assembly during Protrusion and
FA Maturation and Disassembly before Retraction
The above results show that EGF induces a rapid contraction
that is required for a temporally delayed retraction event. To
test if the lag between contraction and retraction is due to a
delay in de-adhesion, we analyzed FA dynamics after EGF
stimulation. We used paxillin as a marker of FAs, because it
Figure 3. EGF stimulation promotes myosin-IIA heavy
chain (MHC) localization on F-actin bundles in the la-
mella and S19-MRLC phosphorylation. (A) Epifluores-
cence images of HaCat cells fixed at the noted times
(min) after 5 nM EGF stimulation and processed for
localization of F-actin, MHC, and pS19-MRLC (0 min,
n  21; 5 min, n  21; 20 min, n  24). Below, enlarged
views of the regions denoted by the white squares. Bars,
10 m. (B) Left, Western blots of cell lysates collected
after stimulation with 5 nM EGF probed for pS19-MRLC
and actin as a loading control. Times after EGF stimu-
lation are noted in minutes. Right, quantification of
Western blotting for pS19-MRLC normalized to actin.
Inset, enlargement of the 0–3-min time points. Error
bars, SEM; n  3.
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is present in FAs of various maturation states (Laukaitis et
al., 2001; Zaidel-Bar et al., 2007b; Choi et al., 2008). To avoid
confusion in terminology, we call all ventral paxillin-con-
taining clusters “FAs” regardless of their size, shape, or
position in the cell. Before EGF stimulation, immunolocal-
ization of paxillin showed that FAs exhibited a range of sizes
and fluorescence intensities. EGF induced an increase in the
fraction of small FAs (0.5 m2) at 5 min PS (Figure 6A),
mostly within the lamellipodium (Figure 6A). The shift in
the FA size distribution after EGF stimulation resulted in a
significantly (Kolmogorov-Smirnov, p  0.001) smaller av-
erage FA size and was accompanied by a significant increase
in average normalized FA fluorescence (Figure 6B). By 20
min PS, the average FA size returned to the larger prestimu-
lus level, although a majority of these were extended, nar-
row, and dim in fluorescence and remained behind the
retracted cell edge (Figure 6, A and B).
To better analyze the kinetics of this process, we trans-
fected cells with either paxillin-EGFP or -mCherry and im-
aged them using TIRF microscopy during EGF stimulation
(Supplemental Video 4). The intensity of segmented FAs
was normalized to cytosolic paxillin fluorescence, multiplied
by the segmented area, and ratioed to the prestimulus value
to give a normalized measure of paxillin in FAs with respect
to the prestimulus level. Increases included both new FA
assembly and paxillin recruitment to existing FAs. Analysis
of individual FAs that were present before EGF stimulation
showed that EGF induced recruitment of paxillin, and most
of these preexisting FAs began to elongate and treadmill or
slide centripetally within 2–5 min after EGF treatment (Fig-
ure 6D). Analysis of all segmented FAs within a cell showed
that at 4 min PS, paxillin increase in FAs peaked, followed
by a slow decay that continued through the retraction event
(Figure 6, C and E). Thus, EGF stimulates rapid assembly of
small FAs concomitant with cell protrusion, followed by FA
growth mediated by recruitment of paxillin to both newly
formed and existing FAs and subsequent dissociation of
paxillin from FAs and their disassembly during retraction.
Dephosphorylation of paxillin on Y118 is a biochemical
marker of FA maturation (Zaidel-Bar et al., 2007b). Unfortu-
nately, we were unable to reliably immunofluorescently lo-
calize pY118-paxillin because of a strongly reactive band at
a molecular weight distinct from that of paxillin in immu-
noblots after EGF stimulation (not shown). However, immu-
noblots could reliably report the level of pY118- paxillin in
whole cell lysates from EGF stimulated cells (Figure 6E).
This analysis revealed a slight dip or lag in pY118-paxillin
for 1 min PS, followed by a rapid increase above the basal
level that reached a maximum at 3 min and that was com-
parable to the relative increase in fluorescent paxillin in FAs
measured by microscopy and similar to the timing of EGF-
stimulated protrusion. This was followed by a subsequent
decrease in pY118-paxillin toward the basal level before the
cell retraction. Together these results suggest that EGF stim-
Figure 4. ROCK activity is required
for EGF-stimulated cell retraction and
S19-MRLC phosphorylation. (A) Left:
DIC images of HaCat cells at different
times (in min) after 5 nM EGF stimu-
lation. Cells were pretreated with ve-
hicle only (0.3% DMSO), 20 M ML-7,
30 M blebbistatin, or 10 M Y-27632
for 1–2 h before stimulation with EGF,
as indicated to the left. Bars, 10 m.
Right, kymographs taken along the
lines highlighted in the 0-min images,
with time after EGF stimulation (min)
below. (B) Quantification of cell area
changes normalized to the mean area
of control cells before EGF stimula-
tion. Error bars, SEM for each con-
dition (control, n  10, F; ML-7, n 
10, f; blebbistatin, n  10, ; and
Y-27632, n 10, Œ). (C) Quantification
of Western blotting for pS19-MRLC
normalized to total MRLC. Error bars,
SEM for each condition (control, n
4, F; ML-7, n 2, f; and Y-27632, n
2, Œ).
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ulates the assembly of FAs and recruitment and phosphor-
ylation of paxillin on Y118, followed by Y118 paxillin de-
phosphorylation, indicating FA maturation and finally FA
disassembly and cell retraction.
EGF-induced Contraction Drives FA Maturation
We next sought to determine how EGF promotes FA growth
and maturation. This could be triggered by EGF-induced
biochemical signals. Alternatively, because myosin-II–medi-
ated contraction drives FA growth, maturation could be
driven by EGF-dependent myosin-II–mediated mechanical
signals. To determine how myosin-II contributes to EGF-
stimulated FA changes, we first examined FA morphology
by immunofluorescence after EGF stimulation in pharmaco-
logically perturbed cells. Before EGF stimulation, inhibition
of either myosin-II ATPase with blebbistatin or ROCK ac-
tivity with Y-27632 inhibited large FAs, and cells exhibited
diffuse paxillin staining and many small FAs near the cell
edge (Figures 7A, Supplemental Figures S1 and S2A). After
EGF stimulation, FAs in blebbistatin-treated cells were un-
changed (Figure 7A), whereas in Y-27632–treated cells some
small FAs near the cell edge elongated slightly at 5 min PS
(Figure S2A), agreeing with the slight increase in pS19-
MRLC observed behind lamellipodia after Y-27632 treat-
ment and EGF stimulation (Figure 5). TIRF imaging of bleb-
bistatin- and Y-27632–treated cells expressing paxillin-EGFP
or -mCherry revealed no appreciable recruitment of paxillin
to FAs after EGF stimulation (Figure 7, B and C, Supplemen-
tal Figure S2C, and Supplemental Video 5). Thus, EGF-
induced paxillin recruitment and FA growth is dependent
on ROCK-mediated myosin-II contraction.
To determine the role of myosin-II in the biochemical
aspects of FA maturation, we analyzed Y118-paxillin phos-
phorylation by immunoblot in cells treated with contraction
inhibitors. As noted, control cells stimulated with EGF ex-
hibit a rapid increase in pY118-paxillin phosphorylation fol-
lowed by a decrease after 10 min PS (Figure 6E). Surpris-
ingly, in the presence of blebbistatin, EGF stimulation
induced rapid and extensive reduction in pY118-paxillin
level (Figure 7C). Phosphorylation of paxillin on Y118 can be
controlled through Fak activity (Schaller and Parsons, 1995).
Therefore, we examined the level of activated Fak (pY397-
Fak) by immunoblot. Although pY397-Fak did not show an
increase after EGF stimulation, in the presence of blebbistatin,
EGF induced a dramatic decrease in level of pY397-Fak, similar
to the kinetics of pY118-paxillin dephosphorylation (Figure
Figure 5. ROCK is required for S19-
MRLC phosphorylation in the cell cen-
ter, but not in the cell periphery. Top,
epifluorescence images of HaCat cells
fixed after pretreatment for 1–2 h with
10 M Y-27632 and 0, 5, and 20 min of
5 nM EGF stimulation. Cells were pro-
cessed for localization of F-actin, MHC,
and pS19-MRLC. Bottom, enlarged
views of the regions denoted by the
white squares. Bars, 10 m.
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7C). Together, these results show that myosin-II–mediated con-
traction is required for EGF-stimulated Y118-paxillin phos-
phorylation, which counteracts an EGF-mediated signal for the
deactivation of Fak and dephosphorylation of Y118 on paxillin.
Although these experiments show that EGF-induced pax-
illin recruitment, FA growth and Y118-paxillin phosphory-
lation requires myosin-II activity, it does not determine spe-
cifically if the myosin-II activity spike stimulated by EGF is
required or if a basal level of myosin-II activity may be
sufficient for these responses. Furthermore, because myo-
sin-II inhibition locks FAs in an immature state, it is unclear
if some level of FA size is required before FAs are receptive
to a growth/maturation signal from EGF. To sort out these
issues, we added EGF and Y-27632 to cells simultaneously,
so that FAs were in various states of assembly, maturation,
and disassembly upon EGF stimulation and myosin-II inhi-
bition. By immunoblot, we verified that acute Y-27632 treat-
ment blocked EGF-stimulated increases in pS19-MRLC (Fig-
ure 8C). Simultaneous induction of EGF signaling and
inhibition of contraction resulted in normal cell protrusion
kinetics (2 min, Figure 8A), allowed FA formation in the
protruding lamellipodium, but blocked the further growth
of these FAs (Figure 8B) and blocked the cell retraction
response (Figure 8, A and B, and Supplemental Video 6).
Similarly, immunoblots of cell lysates showed that cells
simultaneously treated with blebbistatin and EGF did not
exhibit the increase in Y118-paxillin phosphorylation seen
after stimulation with EGF alone (Figure 8D). However, in
contrast to EGF stimulation of blebbistatin-pretreated cells,
cells simultaneously treated with EGF and blebbistatin did not
exhibit an immediate decrease in pY118-paxillin level, support-
ing the role of basal contraction in initial Y118-paxillin dephos-
phorylation (Figure 8D). Overall, these results show that EGF-
stimulated, ROCK-dependent contraction is required for the
effects of EGF on FA growth and maturation.
Paxillin Dephosphorylation Contributes to the
EGF-induced Retraction Response
Because paxillin phosphoregulation on Y31 and Y118 is
involved in FA maturation and/or disassembly (Zaidel-Bar
et al., 2007), we sought to determine if regulation at these
sites was necessary for the EGF-induced cell retraction re-
Figure 6. EGF stimulation promotes FA as-
sembly and growth, followed by maturation
and disassembly. (A) Left, epifluorescence im-
ages of HaCat cells that were stimulated with 5
nM EGF for 0, 5, and 20 min as noted and fixed
and processed for localization of F-actin and
paxillin. Center, enlarged views of the regions
denoted by the white squares. Arrows denote
small assembled FAs. Bars, 10 m. Right, histo-
gram of FA size distribution (n  4–7 cells). (B)
Left, semi-log plot of the normalized paxillin
fluorescence in FAs (background subtracted FA
paxillin fluorescence divided by the back-
ground subtracted cytosolic paxillin fluores-
cence) versus FA size at different times after
EGF stimulation (PS, 0 green, 5 red, and 20
blue). Lines represent linear fits to the data.
Right, the average area (dark bars) or normal-
ized paxillin fluorescence (light bars) of FAs
after 0 (green), 5 (red), and 20 (blue) min of
EGF stimulation. Error bars, SEM. (C) Graph
of the normalized cell area (gray, right axis) and
paxillin-EGFP in FAs (gray, left axis) for the cell
in D. (D) Top row, TIRF images of a cell ex-
pressing paxillin-EGFP at the times noted after
stimulation with 5 nM EGF, with enlarged
views of the region highlighted by a white box.
Bottom row, FA segmented as described in Ma-
terials and Methods. Arrows denote small, newly
assembled FAs. Bars, 10 m. (E) Left, Western
blots of cell lysates probed for pY118-paxillin
and total paxillin at the noted times after EGF
stimulation. Center, the average normalized
paxillin-EGFP fluorescence in FAs (n  5 cells,
black) and the average of quantified Western
blots of pY118-paxillin level normalized to total
paxillin level (n 3, red). Right, enlargement of
the 0–3 min time points plotted in the center
graph. Error bars, SEM.
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sponse. We used siRNA to inhibit expression of endogenous
paxillin (reducing paxillin levels by 90%; Supplemental Fig-
ure S3) and reexpressed EGFP-fused wild-type, nonphosphor-
ylatable (Y31F/Y118F), or phosphomimic (Y31E/Y118E) mu-
tants of paxillin (Zaidel-Bar et al., 2007b). Both mutant and
wild-type paxillin-enhanced green fluorescent protein
(EGFP) proteins localized normally to FAs (Figure 9A), and
all exhibited a normal protrusion response to EGF stimula-
tion. To determine effects on EGF-induced retraction, we
used kymograph analysis of image series and scored
whether cells retracted within 30 min PS. This showed that
both knockdown of endogenous paxillin or replacement of
endogenous paxillin with EGFP-phosphomimic paxillin mu-
tant inhibited the EGF-induced retraction response com-
pared with untransfected cells or cells in which endogenous
paxillin was replaced with either wild-type or nonphosphor-
ylatable EGFP-paxillins (Figure 9B, Supplemental Video 7).
Interestingly, cells with the phosphomimic replacing endog-
enous paxillin contained large FAs at the leading edge, even
30 min after EGF stimulation (Figure 9A). Taken together,
these results indicate that paxillin is required for EGF in-
duced cell retraction, and that paxillin dephosphorylation is
required for FA disassembly to mediate this process.
DISCUSSION
This work provides mechanistic insight into the kinetic con-
trol of protrusion, adhesion, traction generation, and retrac-
tion during cell migration. Understanding how these events
are temporally ordered has been elusive, because cells un-
dergoing steady-state migration may protrude, adhere, gen-
erate traction, and retract at many different places and times
within the cell. The ensemble average of these individually
timed cycles may determine the net movement of the whole
cell. By using acute EGF stimulation of migration, we were
able to synchronize these normally asynchronous cycles. We
found that EGF stimulation elicits protrusion at 2 min PS,
which was followed by retraction at 10 min PS, thus de-
fining, under synchronous conditions, the duration of a full
cell migration cycle in epidermal keratinocytes. Surpris-
ingly, we found that the intervening events, adhesion, and
traction generation, are not initiated at intermediate time
points, but rather that protrusion, adhesion, contraction, and
traction generation all are initiated within 2 min after EGF
stimulation, followed by a lag of 10 min before retraction.
Supplemental Table S1 and Figure 9C outline the kinetics
of protrusion, FA characteristics, myosin-II regulation, and
Figure 7. Myosin-II is required for EGF-medi-
ated recruitment of paxillin to FAs and modu-
lates phosphorylation and dephosphorylation
of paxillin and Fak. (A) Epifluorescence images
of HaCat cells that were pretreated for 1–2 h
with 30 M blebbistatin and then stimulated
with 5 nM EGF for 0, 5, and 20 min as noted and
then fixed and processed for localization of F-
actin and paxillin. Right, enlarged views of the
regions denoted by the white squares. (B) TIRF
images of paxillin-mCherry in cells similarly
pretreated with 30 M blebbistatin and stimu-
lated with 5 nM EGF. Time after EGF stimula-
tion in min is shown. Bottom, enlarged views of
the region highlighted by a white box. Bars, 10
m. (C) Left, Western blots of lysates of cells
that had been either pretreated for 1–2 h with 50
M blebbistatin (blebb.) or not (control) before
stimulation with 5 nM EGF. Blots probed for
pY118-paxillin and total paxillin (top four pan-
els) or pY397 FAK or total FAK (bottom four
panels) at the noted times after EGF stimula-
tion. Right, the average was normalized paxil-
lin-EGFP fluorescence in FAs (n  4 cells,
black), and the average of quantified Western
blots of pY118-paxillin level was normalized to
total paxillin level (n  2, red) in blebbistatin–
pretreated cells stimulated with 5 nM EGF. Er-
ror bars, SEM.
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traction generation and retraction that occur after EGF stim-
ulation. After EGF stimulation, S19-MRLC phosphorylation
is initiated first (tlag  15 s and tmax  15–30 s), followed by
traction force generation (tlag  20 s and tmax  7.4 min).
Before the traction force reaches its maximum, paxillin is
assembled in new FAs and recruited to existing FAs (tlag 
Figure 8. EGF-stimulated, ROCK-dependent contraction is required for EGF-induced paxillin recruitment and FA growth. (A) Left,
phase-contrast images at various times (in minutes) after stimulation with either 5 nM EGF alone (top row) or EGF with 10 M Y-27632
(bottom row). Right, kymographs taken along the lines highlighted in the 0-min images, with time after stimulation (min) below. (B)
Epifluorescence images of cells stimulated with 5 nM EGF and 10 mM Y-27632 simultaneously, fixed, and processed for localization of F-actin,
MHC, and paxillin. Time after stimulation (in min) is shown. Color overlays show higher magnification of the area highlighted by a white
box. Bars, 10 m. (C) Left, Western blots of cell lysates probed for pS19-MRLC and total MRLC, collected after stimulation with 5 nM EGF
alone (top two panels) or 5 nM EGF with 10 M Y-27632 (bottom two panels) for the indicated times (in min). Right, quantification of Western
blotting for pS19-MRLC normalized to total MRLC. Error bars, SEM for each condition (control, n  4, F; Y-27632, n  2, Œ). (D) The
average of quantified western blots of pY118-paxillin level normalized to total paxillin level is shown (5 nM EGF, n  7, F; 5 nM EGF  30
M blebbistatin simultaneously, n  3, f; 5 nM EGF  30 M blebbistatin pretreatment, n  3, ; 30 M blebbistatin alone, n  2, Œ).
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1.6 min and tmax  5.2 min) and paxillin Y118 is phosphor-
ylated (tlag  1.1 min and tmax  3.0 min). Surprisingly,
protrusion shows slower kinetics and lags behind the sig-
naling and traction responses (tlag  1.9 min and tmax  7.8
min), but is concomitant with adhesion assembly. Finally,
retraction ensues with a tlag  11.2 min. These results sug-
gest that the increase in traction force at 2 min PS is
mediated by much more rapid activation of contraction,
followed closely by increased adhesion. The contraction in-
crease was indicated by ROCK-dependent MRLC phosphory-
lation, implicating EGF in the rapid activation of RhoGTPase
signaling. Increased adhesion was indicated by up-regulation
of paxillin phosphorylation and formation of many small, pre-
sumably biochemically immature FAs. The delay between
myosin-II activation and traction generation is surprising
and likely represents the time for myosin-II filament assem-
bly (Dulyaninova et al., 2007), transmission of forces through
the actin cytoskeleton to FAs and the formation and growth
of FAs capable of transmitting these forces to the ECM. The
precedence of Y118-paxillin phosphorylation before focal
adhesion growth implies that this phosphoregulation may
be required for growth.
Contraction Drives FA Maturation to Time a Delay in
Cell Retraction
Our results suggest the existence of an EGF-stimulated
switch in tension sensing at the level of FA maturation and
adhesive strength. Adherent cells exist in a homeostatic state
Figure 9. EGF-mediated retraction depends on
paxillin dephosphorylation. (A) Left and right, epi-
fluorescence images of EGFP-tagged wild-type
and mutant paxillins before and after the phase-
contrast time course. Center, phase-contrast im-
ages of cells after EGF stimulation (time in min).
Bars, 10 m. (B) Fraction of cells that retracted
within 30 min after stimulation with EGF. (C) Time
line of the lags (left bar) and maximum levels
(right bar) of the cellular outputs measured after
EGF stimulation in the presence and absence of
myosin-II activity. (D) Arrow diagram explaining
how EGF regulates retraction. Red areas corre-
spond to early events, and green areas correspond
to late events.
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where the contractile strength almost matches the adhesion
strength (Powers et al., 1997). This close matching between
contraction and adhesion strengths occurs because of feed-
back loops between them. Consequently, cells tend not to
have excess adhesion strength. In order for a cell (or a
protrusion) to retract, the cell must either increase contrac-
tion or decrease adhesion. Although we found that EGF
induced a robust increase in myosin-II activity, this occurred
well before retraction and was nearly cotemporal with pro-
trusion and increased traction force generation (Figure 9B).
Because this early rise in contraction and traction did not
induce retraction, it must have been balanced by increased
adhesion, as indicated by the myosin-II–dependent assembly
and recruitment of phosphorylated paxillin to FAs. However,
after the protrusion phase and preceding the retraction phase,
contraction decreased slightly and FA maturation mediated by
pY118-paxillin dephosphorylation ensued, eventually allowing
FA disassembly to decrease adhesion strength, and thus pro-
moting the subsequent retraction.
We suggest that EGF-mediated contractility drives a FA
maturation cycle that acts as a 10-min timer, regulating a
switch between high adhesion and low adhesion. This ad-
hesion switch cooperates with sustained contraction to gen-
erate traction force at early times and retraction much later,
as pictured in Figure 9D. EGF stimulates leading edge pro-
trusion that is tightly coupled with the formation of new
FAs. The “maturation timer cycle” is initiated as newly
assembled FAs are immediately acted on by the EGF-stim-
ulated myosin-II activity spike to promote FA growth, drive
Y118 paxillin phosphorylation and increase traction force. Im-
portantly, in the absence of contractile activity, EGF induced
small FAs and immediate paxillin and Fak dephosphorylation,
suggesting that EGF promotes biochemical signals that drive
Fak inactivation and paxillin dephosphorylation, but that
these are overridden by the myosin-II–mediated mechanical
signals driving adhesion assembly and paxillin phosphory-
lation. Once the FA assembly and growth process has ceased
(5 min PS), myosin-II activity decreases, ending the con-
traction-induced up-regulation of paxillin phosphorylation
and allowing the EGF-mediated biochemical signal driving
pY118-paxillin dephosphorylation to dominate, likely medi-
ated by both Fak down-regulation and phosphatase activity.
This delayed paxillin dephosphorylation is required for FA
disassembly and adhesion weakening, because blocking
paxillin expression or inhibiting paxillin dephosphorylation
by replacing the endogenous protein with a phosphomimic
mutant prevented FA disassembly and cell retraction. Once
FA maturation and weakening occurs, the sustained myo-
sin-II–mediated contraction that remains elevated through
20 min PS switches its role from generating traction to
driving retraction. We suggest that the paxillin phosphory-
lation-dephosphorylation cycle sets the timing of FA matu-
ration and is the root cause of the delay between initial
traction generation and retraction. This scenario agrees with
data showing that blocking myosin-II function slows focal
adhesion disassembly (Webb et al., 2004). Thus, our results
suggest the existence of an EGF-stimulated switch in tension
sensing at the level of focal adhesion maturation and adhe-
sive strength and indicate that, contrary to the notion that
adhesion maturation is inhibitory to migration, the process
is critical to the timing of events during the cell migration
cycle.
Myosin-II–mediated Contraction May Affect
EGF-mediated Signaling, Metastasis, and Chemotaxis
The dramatically different kinetics of EGF-stimulated paxil-
lin phosphorylation/dephosphorylation, depending on the
contractile state of the cell illustrates a very interesting fea-
ture of EGF-mediated signaling pathways, i.e., their depen-
dence on intracellular tension. This difference in signaling
could play a role in pathological processes such as cancer
cell behavior. Tumors are stiffer than the surrounding tis-
sues, thus affecting the level of contractility in cells within
tumors, which likely affects their response to EGF signaling
(Paszek et al., 2005). In soft environments, lower levels of cell
contractility could reduce EGF-mediated paxillin phosphor-
ylation, thus inhibiting cell traction and preventing migra-
tion, whereas in stiff tumors the EGF-mediated contraction
could be higher, leading to FA strengthening and matura-
tion to facilitate migration out of the tumor. It is also possible
that EGF-induced maturation of FAs may serve as a point of
control for chemotaxing cells. In steep chemoattractant gra-
dients, chemotaxis is thought to proceed by biasing protru-
sion; however, it was shown recently that cells migrating in
very shallow chemoattractant gradients extend multiple
protrusions, even in unproductive directions (Andrew and
Insall, 2007). Perhaps protrusions that are exposed to higher
chemoattractant concentrations activate contraction in a way
that stabilizes adhesion to the surface, whereas protrusions
that are exposed to lower chemoattractant concentration
activate contraction to a lesser extent.
In summary, kinetic analysis of EGF-mediated protrusion
has already been carried out with success (Mouneimne et al.,
2004); however, until now there was limited information on
the kinetics of the processes of adhesion, contraction, trac-
tion generation, and retraction. This kinetic information on
EGF-stimulated adhesion and contraction is vital in under-
standing how the cell might temporally segregate the pro-
cesses of traction force generation and retraction during cell
migration in wound healing, metastasis, and chemotaxis.
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